Japan’s FY2027 budget requests for R&D programs under the Japan Agency for Medical Research and Development (AMED) total 453.8 billion yen, more than triple the initial FY2026 budget of 123.8 billion yen, as the government looks to ramp up investment…
To read the full story
Related Article
- MHLW Seeks Record 36.6 Trillion Yen for FY2027, Puts AI in Focus
August 27, 2026
REGULATORY
- Lilly’s Oral GLP-1 Obesity Drug Heads to Dec. 2 Panel Review, Eyes Japan First
November 19, 2026
- First Pralia Biosimilars Inching Closer to Japan Approval, 5 Products Lined Up
November 19, 2026
- MHLW Drug Supply Monitoring System Hit by Cyberattack, Possible Data Leak
November 19, 2026
- Japan’s FY2027 AMED Budget Requests Top 450 Billion Yen
November 19, 2026
- Expert Calls for Remote MRI Reviews to Monitor Alzheimer’s Drug Risks
November 18, 2026
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…





